Transact Technologies (TACT)

8.02 -0.17  -2.08%  May 17, 8:00PM
Add to Watchlists Create an Alert

Transact Technologies R&D Expense Quarterly:

0.987M for Dec. 31, 2012
View Full Chart

Transact Technologies R&D Expense Quarterly Chart

    Transact Technologies Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 0.987M
    Sept. 30, 2012 1.087M
    June 30, 2012 0.952M
    March 31, 2012 1.213M
    Dec. 31, 2011 0.986M
    Sept. 30, 2011 0.848M
    June 30, 2011 0.815M
    March 31, 2011 0.769M
    Dec. 31, 2010 0.739M
    Sept. 30, 2010 0.717M
    June 30, 2010 0.799M
    March 31, 2010 0.745M
    Dec. 31, 2009 0.745M
    Sept. 30, 2009 0.683M
    June 30, 2009 0.666M
    March 31, 2009 0.694M
    Dec. 31, 2008 0.823M
    Sept. 30, 2008 0.713M
    June 30, 2008 0.691M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    TACT R&D Expense Quarterly Benchmarks

    Companies
    Astro-Med 0.2784M
    Synaptics 36.74M
    Stratasys 7.083M

    TACT R&D Expense Quarterly Rankings

    Overall 83rd percentile
    1251 of 7593
    Sector 38th percentile
    558 of 905 in Technology
    Industry 20th percentile
    23 of 29 in Computer Systems

    TACT R&D Expense Quarterly Range, Past 5 Years

    Minimum 0.6660M Jun 2009
    Maximum 1.213M Mar 2012
    Average 0.8248M